Showing results (281-290 of 1,869) with videos related to
Sort By:
Pageof 187
Current Cancer Drug Targets|January 10, 2017
Recent Advances in Application of Poly-Epsilon-Caprolactone and its Derivative Copolymers for Controlled Release of Anti-Tumor DrugsZhiqiang Sun, Ranglong Duan, Dejun Xing, et al.Current Cancer Drug Targets|January 10, 2017
Histone Deacetylase Inhibitors for the Treatment of Colorectal Cancer: Recent Progress and Future ProspectsAvineesh Singh, Preeti Patel, Vijay K Patel, et al.Current Cancer Drug Targets|December 29, 2016
A Rational Approach to Target the Epidermal Growth Factor Receptor in GlioblastomaMadan M KwatraCurrent Cancer Drug Targets|April 12, 2014
PET imaging with [⁶⁸Ga]NOTA-RGD for prostate cancer: a comparative study with [¹⁸F]fluorodeoxyglucose and [¹⁸F]fluoroethylcholineIna Israel, Dominik Richter, Jochen Stritzker, et al.Current Cancer Drug Targets|April 12, 2014
Co-formulation of P-glycoprotein Substrate and Inhibitor in Nanocarriers: An Emerging Strategy for Cancer ChemotherapyAnkit Saneja, Ravindra Dhar Dubey, Noor Alam, et al.Current Cancer Drug Targets|October 15, 2016
EGFR High Expression, but not KRAS Status, Predicts Sensitivity of Pancreatic Cancer Cells to Nimotuzumab Treatment In VivoChenfei Zhou, Liangjun Zhu, Jun Ji, et al.Current Cancer Drug Targets|November 23, 2012
Experimental therapy for lung cancer: umbilical cord-derived mesenchymal stem cell-mediated interleukin-24 deliveryXu Zhang, Leilei Zhang, Wenrong Xu, et al.Current Cancer Drug Targets|September 27, 2014
Heat shock proteins as prognostic markers of cancerEvgeniya V Kaigorodova, Mariya V BogatyukCurrent Cancer Drug Targets|August 5, 2014
CRIM1, the antagonist of BMPs, is a potential risk factor of cancerHui Zeng, Liling TangCurrent Cancer Drug Targets|October 31, 2013
Regulation of EMT by KLF4 in gastrointestinal cancerJiujie Cui, Min Shi, Ming Quan, et al.Pageof 187